The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cox-2 Inhibitors Market Research Report 2024

Global Cox-2 Inhibitors Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 1718774

No of Pages : 70

Ask Your Query
Synopsis
Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.
The global Cox-2 Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Cox-2 Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cox-2 Inhibitors.
Report Scope
The Cox-2 Inhibitors market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cox-2 Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cox-2 Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
Segment by Type
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cox-2 Inhibitors companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cox-2 Inhibitors Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Selective Cox-2 Inhibitors
1.2.3 Non Selective Cox-2 Inhibitors
1.3 Market by Application
1.3.1 Global Cox-2 Inhibitors Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cox-2 Inhibitors Market Perspective (2019-2030)
2.2 Cox-2 Inhibitors Growth Trends by Region
2.2.1 Global Cox-2 Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cox-2 Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 Cox-2 Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 Cox-2 Inhibitors Market Dynamics
2.3.1 Cox-2 Inhibitors Industry Trends
2.3.2 Cox-2 Inhibitors Market Drivers
2.3.3 Cox-2 Inhibitors Market Challenges
2.3.4 Cox-2 Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cox-2 Inhibitors Players by Revenue
3.1.1 Global Top Cox-2 Inhibitors Players by Revenue (2019-2024)
3.1.2 Global Cox-2 Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Cox-2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cox-2 Inhibitors Revenue
3.4 Global Cox-2 Inhibitors Market Concentration Ratio
3.4.1 Global Cox-2 Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cox-2 Inhibitors Revenue in 2023
3.5 Cox-2 Inhibitors Key Players Head office and Area Served
3.6 Key Players Cox-2 Inhibitors Product Solution and Service
3.7 Date of Enter into Cox-2 Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cox-2 Inhibitors Breakdown Data by Type
4.1 Global Cox-2 Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global Cox-2 Inhibitors Forecasted Market Size by Type (2025-2030)
5 Cox-2 Inhibitors Breakdown Data by Application
5.1 Global Cox-2 Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global Cox-2 Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cox-2 Inhibitors Market Size (2019-2030)
6.2 North America Cox-2 Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cox-2 Inhibitors Market Size by Country (2019-2024)
6.4 North America Cox-2 Inhibitors Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cox-2 Inhibitors Market Size (2019-2030)
7.2 Europe Cox-2 Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cox-2 Inhibitors Market Size by Country (2019-2024)
7.4 Europe Cox-2 Inhibitors Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cox-2 Inhibitors Market Size (2019-2030)
8.2 Asia-Pacific Cox-2 Inhibitors Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cox-2 Inhibitors Market Size by Region (2019-2024)
8.4 Asia-Pacific Cox-2 Inhibitors Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cox-2 Inhibitors Market Size (2019-2030)
9.2 Latin America Cox-2 Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cox-2 Inhibitors Market Size by Country (2019-2024)
9.4 Latin America Cox-2 Inhibitors Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cox-2 Inhibitors Market Size (2019-2030)
10.2 Middle East & Africa Cox-2 Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cox-2 Inhibitors Market Size by Country (2019-2024)
10.4 Middle East & Africa Cox-2 Inhibitors Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Cox-2 Inhibitors Introduction
11.1.4 Bayer Revenue in Cox-2 Inhibitors Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cox-2 Inhibitors Introduction
11.2.4 Novartis Revenue in Cox-2 Inhibitors Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cox-2 Inhibitors Introduction
11.3.4 Pfizer Revenue in Cox-2 Inhibitors Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Cox-2 Inhibitors Introduction
11.4.4 Merck Revenue in Cox-2 Inhibitors Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Cadila Pharmaceuticals
11.5.1 Cadila Pharmaceuticals Company Detail
11.5.2 Cadila Pharmaceuticals Business Overview
11.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Introduction
11.5.4 Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2019-2024)
11.5.5 Cadila Pharmaceuticals Recent Development
11.6 Sabinsa Corporation
11.6.1 Sabinsa Corporation Company Detail
11.6.2 Sabinsa Corporation Business Overview
11.6.3 Sabinsa Corporation Cox-2 Inhibitors Introduction
11.6.4 Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2019-2024)
11.6.5 Sabinsa Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Cox-2 Inhibitors Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Selective Cox-2 Inhibitors
Table 3. Key Players of Non Selective Cox-2 Inhibitors
Table 4. Global Cox-2 Inhibitors Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Cox-2 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cox-2 Inhibitors Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cox-2 Inhibitors Market Share by Region (2019-2024)
Table 8. Global Cox-2 Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cox-2 Inhibitors Market Share by Region (2025-2030)
Table 10. Cox-2 Inhibitors Market Trends
Table 11. Cox-2 Inhibitors Market Drivers
Table 12. Cox-2 Inhibitors Market Challenges
Table 13. Cox-2 Inhibitors Market Restraints
Table 14. Global Cox-2 Inhibitors Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cox-2 Inhibitors Market Share by Players (2019-2024)
Table 16. Global Top Cox-2 Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cox-2 Inhibitors as of 2023)
Table 17. Ranking of Global Top Cox-2 Inhibitors Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Cox-2 Inhibitors Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cox-2 Inhibitors Product Solution and Service
Table 21. Date of Enter into Cox-2 Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cox-2 Inhibitors Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cox-2 Inhibitors Revenue Market Share by Type (2019-2024)
Table 25. Global Cox-2 Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cox-2 Inhibitors Revenue Market Share by Type (2025-2030)
Table 27. Global Cox-2 Inhibitors Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cox-2 Inhibitors Revenue Market Share by Application (2019-2024)
Table 29. Global Cox-2 Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cox-2 Inhibitors Revenue Market Share by Application (2025-2030)
Table 31. North America Cox-2 Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Cox-2 Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Cox-2 Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Cox-2 Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Cox-2 Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Cox-2 Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Cox-2 Inhibitors Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Cox-2 Inhibitors Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Cox-2 Inhibitors Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cox-2 Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Cox-2 Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Cox-2 Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Cox-2 Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Cox-2 Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Cox-2 Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Cox-2 Inhibitors Product
Table 49. Bayer Revenue in Cox-2 Inhibitors Business (2019-2024) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Cox-2 Inhibitors Product
Table 54. Novartis Revenue in Cox-2 Inhibitors Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Cox-2 Inhibitors Product
Table 59. Pfizer Revenue in Cox-2 Inhibitors Business (2019-2024) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Cox-2 Inhibitors Product
Table 64. Merck Revenue in Cox-2 Inhibitors Business (2019-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Cadila Pharmaceuticals Company Detail
Table 67. Cadila Pharmaceuticals Business Overview
Table 68. Cadila Pharmaceuticals Cox-2 Inhibitors Product
Table 69. Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2019-2024) & (US$ Million)
Table 70. Cadila Pharmaceuticals Recent Development
Table 71. Sabinsa Corporation Company Detail
Table 72. Sabinsa Corporation Business Overview
Table 73. Sabinsa Corporation Cox-2 Inhibitors Product
Table 74. Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2019-2024) & (US$ Million)
Table 75. Sabinsa Corporation Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cox-2 Inhibitors Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cox-2 Inhibitors Market Share by Type: 2023 VS 2030
Figure 3. Selective Cox-2 Inhibitors Features
Figure 4. Non Selective Cox-2 Inhibitors Features
Figure 5. Global Cox-2 Inhibitors Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Cox-2 Inhibitors Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Cox-2 Inhibitors Report Years Considered
Figure 11. Global Cox-2 Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cox-2 Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cox-2 Inhibitors Market Share by Region: 2023 VS 2030
Figure 14. Global Cox-2 Inhibitors Market Share by Players in 2023
Figure 15. Global Top Cox-2 Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cox-2 Inhibitors as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cox-2 Inhibitors Revenue in 2023
Figure 17. North America Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cox-2 Inhibitors Market Share by Country (2019-2030)
Figure 19. United States Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cox-2 Inhibitors Market Share by Country (2019-2030)
Figure 23. Germany Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cox-2 Inhibitors Market Share by Region (2019-2030)
Figure 31. China Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cox-2 Inhibitors Market Share by Country (2019-2030)
Figure 39. Mexico Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cox-2 Inhibitors Market Share by Country (2019-2030)
Figure 43. Turkey Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cox-2 Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Bayer Revenue Growth Rate in Cox-2 Inhibitors Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Cox-2 Inhibitors Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Cox-2 Inhibitors Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Cox-2 Inhibitors Business (2019-2024)
Figure 49. Cadila Pharmaceuticals Revenue Growth Rate in Cox-2 Inhibitors Business (2019-2024)
Figure 50. Sabinsa Corporation Revenue Growth Rate in Cox-2 Inhibitors Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock